ERIKA MCCARTY: Open Payments
NPI 1780046102 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 60 payments from 17 companies in 2025. Trend: 2023 $864 · 2024 $1,430 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $207 |
| Merck Sharp & Dohme LLC | 10 | $182 |
| Abbott Laboratories | 8 | $151 |
| Philips North America LLC | 4 | $144 |
| PFIZER INC. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Boston Scientific Corporation | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
Products named: LEQVIO, VERQUVO, Ambulatory Monitoring & Diagnostics Undivided, VYNDAQEL, AVEIR, CAMZYOS, Kerendia, FUROSCIX.
Industry payments across SC — which companies pay providers there.
